Benefits and problems of transarterial therapy in patients with hepatocellular carcinoma and chronic kidney disease. [electronic resource]
Producer: 20150805Description: 1947-55; quiz 1955 p. digitalISSN:- 1535-7732
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Hepatocellular -- complications
- Chemoembolization, Therapeutic -- methods
- Cisplatin -- administration & dosage
- Cohort Studies
- Combined Modality Therapy -- methods
- Epirubicin -- administration & dosage
- Ethiodized Oil -- administration & dosage
- Feasibility Studies
- Female
- Gelatin Sponge, Absorbable -- administration & dosage
- Humans
- Kidney Failure, Chronic -- complications
- Liver Neoplasms -- complications
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.